Figure 2
Figure 2. IELs from RCD cell line P1 proliferate in response to IL-15 in a dose-dependent manner. (A) Proliferation in response to various doses of IL-15. (B) Five-day follow-up of proliferation in response to IL-2, IL-15, and a combination of both. CPM indicates 3H-thymidine incorporation.

IELs from RCD cell line P1 proliferate in response to IL-15 in a dose-dependent manner. (A) Proliferation in response to various doses of IL-15. (B) Five-day follow-up of proliferation in response to IL-2, IL-15, and a combination of both. CPM indicates 3H-thymidine incorporation.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal